CollPlant Biotechnologies Ltd Cash And Cash Equivalents
CollPlant Biotechnologies Ltd (CLGN) had Cash And Cash Equivalents of $3.79 million as of 2019-12-31, per its 20-F filed 2020-04-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
ifrs-full:CashAndCashEquivalents · last filed 2020-04-01
- 2018-12-31: Cash And Cash Equivalents 20.07M ILS.
- 2018-06-30: Cash And Cash Equivalents 9.36M ILS.
- 2017-12-31: Cash And Cash Equivalents 17.82M ILS.
- 2017-06-30: Cash And Cash Equivalents 4.54M ILS.
ILS
| Period end | Cash And Cash Equivalents |
|---|---|
| 2018-12-31 | 20.07M ILS 20-F · filed 2019-04-01 |
| 2018-06-30 | 9.36M ILS 6-K · filed 2018-09-21 |
| 2017-12-31 | 17.82M ILS 20-F · filed 2019-04-01 |
| 2017-06-30 | 4.54M ILS 6-K · filed 2018-09-21 |
| 2016-12-31 | 3.80M ILS 20-F · filed 2019-04-01 |
| 2015-12-31 | 5.32M ILS 20-F · filed 2019-04-01 |
| 2014-12-31 | 11.06M ILS 20-F · filed 2018-03-20 |
USD
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2019-12-31 | $3.79M 20-F · filed 2020-04-01 | |
| 2019-06-30 | $1.74M 6-K · filed 2019-09-26 | |
| 2018-12-31 | $5.35M 20-F · filed 2020-04-01 | |
| 2018-06-30 | $2.56M 6-K · filed 2019-09-26 | |
| 2017-12-31 | $5.14M 6-K · filed 2019-09-26 | |
| 2016-12-31 | $1.32M 6-K · filed 2018-09-21 | $1.09M 20-F · filed 2018-03-20 |